VMP 42274711000001109

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Mirtazapine 30mg tablets
BNF code 0403040X0AAAAAA
Virtual Therapeutic Moiety Mirtazapine
Date identifier became valid 22 Sep 2023
Previous product identifier 321998002
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Mirtazapine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 30.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Mirtazapine 30mg tablets (A A H Pharmaceuticals Ltd)
Mirtazapine 30mg tablets (Accord-UK Ltd)
Mirtazapine 30mg tablets (Alliance Healthcare (Distribution) Ltd)
Mirtazapine 30mg tablets (Almus Pharmaceuticals Ltd)
Mirtazapine 30mg tablets (Crescent Pharma Ltd)
Mirtazapine 30mg tablets (Ennogen Healthcare Ltd)
Mirtazapine 30mg tablets (Genesis Pharmaceuticals Ltd)
Mirtazapine 30mg tablets (Medihealth (Northern) Ltd)
Mirtazapine 30mg tablets (Medreich Plc)
Mirtazapine 30mg tablets (Milpharm Ltd)
Mirtazapine 30mg tablets (Noumed Life Sciences Ltd)
Mirtazapine 30mg tablets (Phoenix Healthcare Distribution Ltd)
Mirtazapine 30mg tablets (Relonchem Ltd)
Mirtazapine 30mg tablets (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Mirtazapine 30mg tablets 28 tablet
Mirtazapine 30mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback